Editas Medicine Inc

NASDAQ:EDIT  
33.21
+1.81 (+5.76%)
Products

Editas Medicine Announces Submission Of Ind Application For Edit-301 With The FDA

Published: 12/09/2020 21:10 GMT
Editas Medicine Inc (EDIT) - Editas Medicine Announces Submission of Ind Application for Edit-301 With the FDA.